1Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective [J]. CNS Drugs,2001,15(6) :469-494.
2Dervaux A, Laqueille X. Tobacco and schizophrenia: therapeutic aspects[J]. Encephale, 2007,33 (4 Pt 1) .. 629-632.
3Kroon LA. Drug interactions with smoking[J]. Am J Health Syst Pharm,2007,64(18) :1917-1921.
4Brosen K. Drug interactions and the cytochrome P450 system. The role of cytoehrome P450 1A2 [J]. Clin Pharmaeokinet, 1995,29(Suppl 1) :20-25.
5Papetti F, Morel-Pingault V, Buisse V, et al. Clozapineresistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports[J]. Encephale, 2007, 33(5) :811-818.
6Lu ML, Lane HY, Chen KP, et al. Fluvoxamine reduces the elozapine dosage needed in refractory schizophrenic patients [J]. J Clin Psychiatry,2000,61 (8) :594-599.
7Heeringa M,Beurskens R, Schouten W, et al. Elevated plasma levels of clozapine after concomitant use of fluvoxamine[J]. Pharm World Sci,1999,21(5):243-244.
8Eap CB, Bender S, Jaquenoud Sirot E, et al. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1 A2 gene[J]. J Clin Psyehopharmacol, 2004,24 (2) :214-219.
9Albers IJ,Ozdemir V, Marder SR, et al. Low-dose fluvoxamine an adjunct to reduce olanzapine therapeutic dose requirements., a prospective dose-adjusted drug interaction strategy[J]. J Clin Psychopharmacol, 2005,25 ( 2 ) : 170-174.
10Granfors MT,Backman JT, Laitila J, et al. Oral contraceptives containing e thinyl estradiol and gestodene mrkedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2[J]. Clin Pharmacol Ther, 2005,78 (4) : 400-411.
